Cargando…

Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism

In cancer patients treated for venous thromboembolism (VTE), including deep-vein thrombosis (DVT) and pulmonary embolism (PE), analyzing mortality associated with recurrent VTE or major bleeding is needed to determine the optimal duration of anticoagulation. This was a cohort study using the Registr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farge, Dominique, Trujillo-Santos, Javier, Debourdeau, Philippe, Bura-Riviere, Alessandra, Rodriguez-Beltrán, Eva Maria, Nieto, Jose Antonio, Peris, Maria Luisa, Zeltser, David, Mazzolai, Lucia, Hij, Adrian, Monreal, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2015
Materias:	3400
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616675/ https://www.ncbi.nlm.nih.gov/pubmed/26266353 http://dx.doi.org/10.1097/MD.0000000000001235

Ejemplares similares

Sex Differences in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism
por: Blanco-Molina, Angeles, et al.
Publicado: (2014)

Platelet Count and Major Bleeding in Patients Receiving Vitamin K Antagonists for Acute Venous Thromboembolism, Findings From Real World Clinical Practice
por: Giorgi-Pierfranceschi, Matteo, et al.
Publicado: (2015)

Prevention of venous thromboembolism in patients with cancer with direct oral anticoagulants: A systematic review and meta-analysis
por: Chen, Hailong, et al.
Publicado: (2020)

Predictors of use of direct oral anticoagulants in patients with venous thromboembolism: Findings from the Registro Informatizado Enfermedad Tromboembólica registry
por: Lorenzo, Alicia, et al.
Publicado: (2022)

Identification of biomarkers of venous thromboembolism by bioinformatics analyses
por: Wang, Guiming, et al.
Publicado: (2018)

Analysis of clinical factors affecting the rates of fatal pulmonary embolism and bleeding in cancer patients with venous thromboembolism
por: Trujillo-Santos, Javier, et al.
Publicado: (2017)

Risk indicators for venous thrombosis in first-degree relatives of patients with recurrent venous thromboembolism in Chinese
por: Zhao, Lianxing, et al.
Publicado: (2016)

Nurses’ objective knowledge regarding venous thromboembolism prophylaxis: A national survey study
por: MA, Yu-Fen, et al.
Publicado: (2018)

Association between thyroid dysfunction and venous thromboembolism: A systematic review and meta-analysis
por: Wang, Yunmeng, et al.
Publicado: (2023)

Association of β-fibrinogen polymorphisms and venous thromboembolism risk: A PRISMA-compliant meta-analysis
por: Li, Da, et al.
Publicado: (2019)

Integrative analyses of genes about venous thromboembolism: An umbrella review of systematic reviews and meta-analyses
por: Lee, Sangyeob, et al.
Publicado: (2022)

Risk profile, management, and outcomes of patients with venous thromboembolism attended in Spanish Emergency Departments: The ESPHERIA registry
por: Jimenez, Sonia, et al.
Publicado: (2017)

Clinical outcomes of comorbid cancer patients with venous thromboembolism: A retrospective, single-center study in Korea
por: Jeong, Jihwan, et al.
Publicado: (2019)

Platelet Count and Bleeding in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism: Lesson from the RIETE Registry
por: Di Micco, Pierpaolo, et al.
Publicado: (2019)

Venous thromboembolism has the same risk factors as atherosclerosis: A PRISMA-compliant systemic review and meta-analysis
por: Mi, Yuhong, et al.
Publicado: (2016)

Multiple arterial and venous thromboembolism in a male patient with hereditary protein C deficiency: A case report
por: Sun, Likun, et al.
Publicado: (2021)

Relationship between thrombomodulin gene polymorphism and susceptibility to venous thromboembolism: A protocol for systematic review and meta-analysis
por: Wei, Meihao, et al.
Publicado: (2021)

A review of venous thromboembolism risk assessment models for different patient populations: What we know and don’t!
por: Mehta, Y, et al.
Publicado: (2023)

Recent advances in the treatment and prevention of venous thromboembolism in cancer patients: role of the direct oral anticoagulants and their unique challenges
por: Farge, Dominique, et al.
Publicado: (2019)

The safety and effectiveness of salvianolate in preventing perioperative venous thromboembolism in China: A PRISMA-compliant meta-analysis based on RCTs
por: Chai, Yu-na, et al.
Publicado: (2021)

The anticoagulants rivaroxaban and low molecular weight heparin prevent PICC-related upper extremity venous thrombosis in cancer patients
por: Lv, Shoutian, et al.
Publicado: (2019)

Spinal anesthesia increases the risk of venous thromboembolism in total arthroplasty: Secondary analysis of a J-PSVT cohort study on anesthesia
por: Nakamura, Mashio, et al.
Publicado: (2017)

Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores
por: Lecumberri, Ramón, et al.
Publicado: (2021)

Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
por: Trujillo‐Santos, Javier, et al.
Publicado: (2022)

Comparing the clinical outcomes in patients with atrial fibrillation receiving dual antiplatelet therapy and patients receiving an addition of an anticoagulant after coronary stent implantation: A systematic review and meta-analysis of observational studies
por: Chaudhary, Nabin, et al.
Publicado: (2016)

Different Types of Statins and All-Cause Mortality during Anticoagulation for Venous Thromboembolism: Validation Study from RIETE Registry
por: Siniscalchi, Carmine, et al.
Publicado: (2020)

Patient and hospital characteristics predictive of inferior vena cava filter usage in venous thromboembolism patients: A study from the 2013 to 2014 Nationwide Readmissions Database
por: Goodin, Amie, et al.
Publicado: (2018)

Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism
por: Moustafa, Farès, et al.
Publicado: (2017)

Impact of betablockers on general and local outcome in patients hospitalized for lower extremity peripheral artery disease: The COPART Registry
por: Mirault, Tristan, et al.
Publicado: (2017)

Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?
por: Mahé, Isabelle, et al.
Publicado: (2015)

Direct Oral Anticoagulants or Standard Anticoagulant Therapy in Fragile Patients with Venous Thromboembolism
por: López-Núñez, Juan J., et al.
Publicado: (2019)

Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism
por: Martínez-Urbistondo, Diego, et al.
Publicado: (2021)

Venous Thromboembolism in Hospitalized Patients With COVID-19 Receiving Prophylactic Anticoagulation
por: Boonyasai, Romsai T., et al.
Publicado: (2020)

Resuming anticoagulation in patients with atrial fibrillation experiencing intracranial hemorrhage
por: Wu, Victor Chien-Chia, et al.
Publicado: (2021)

COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding
por: Demelo-Rodriguez, Pablo, et al.
Publicado: (2023)

Management of Venous Thromboembolism: Recent Advances in Oral Anticoagulation Therapy
por: Finks, Shannon W., et al.
Publicado: (2016)

A case report of PVOD patient combined with pulmonary embolism: Anticoagulation or not?
por: Yuan, Xiaoling, et al.
Publicado: (2017)

Incidence, risk factors, and outcomes of central venous catheter‐related thromboembolism in breast cancer patients: the CAVECCAS study
por: Debourdeau, Philippe, et al.
Publicado: (2017)

A meta-analysis of bridging anticoagulation between low molecular weight heparin and heparin
por: Tao, Ende, et al.
Publicado: (2020)

Fatal vascular complications during transradial percutaneous coronary intervention: A case report
por: Choi, SeongIl, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b2a80hmo6vt4vrm94uiln9jq2o